Rebalix
UBS · sheet of 10 September 2026
UBS · sheet of 10 September 2026ETF sheet · official issuer and register data
UBS S&P 500 Scored & Screened UCITS ETF hGBP dis
IE00BHXMHR72 · IE00BHXMHR72 · GBP · domicile Ireland
Equity · Sustainable / ESGGBP-hedged share classSFDR art. 8
Index tracked: S&P 500 Scored & Screened Hedged to GBP Index (Net Total Return)
- TER
- 0.13%+ trans. 0.00%
- Fund size
- —
- Tracking difference
- +0.08%3-year avg
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Physical
- Income
- Distributingsemi-annual
Launch 25 Mar 2019 · costs from the KID as of 26 Aug 2026 · 2 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 2 Sept 2026
Il Fondo è a gestione passiva e mira a replicare la performance dell'indice S&P 500 Scored & Screened Hedged to GBP Index (Net Total Return) (l'«Indice»). L'Indice è un indice azionario calcolato, mantenuto e pubblicato dal fornitore internazionale di indici S&P Indices ed è denominato in USD. Replica l'andamento delle 500 maggiori società quotate su mercati degli Stati Uniti, ma accessibili a investitori di tutto il mondo. L'Indice presenta un'ampia base e una ponderazione per la capitalizzazione di mercato ed è concepito per generare un'esposizione…
Performance since series start (in euro) — base 100
25 Mar 2019 → 8 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +23.5% |
| 3 years | +75.3% |
| 5 years | +77.9% |
| 10 years | series too young |
| Since series start | +193.2% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 13.12% | 15.12% | 17.34% |
| Max drawdown | −9.77% | −19.69% | −26.84% |
| Sharpe | 1.37 | 1.06 | 0.56 |
| Sortino | 2.04 | 1.56 | 0.80 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · IE00BHXMHR72 · IE00BHXMHR721
RebalixIE00BHXMHR72 · IE00BHXMHR72 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · fund with dividends reinvested by Rebalix on each ex-date (no issuer total-return series); index from the declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +18.44% | +18.34% | +0.11% |
| 2024 | +23.00% | +23.04% | −0.04% |
| 2023 | +25.46% | +25.30% | +0.17% |
| 2022 | −19.94% | −19.97% | +0.03% |
| 2021 | +30.75% | +30.76% | +0.00% |
Distributions · per share, in GBP
Frequency: semi-annual · last 12 months: 0.295 GBP (0.65% of NAV) · last ex-date 13 Aug 2026
| Year | Payments | Total (GBP) | Dividend yield |
|---|---|---|---|
| 2026 | 2 | 0.295 | — |
| 2025 | 2 | 0.3527 | +1.02% |
| 2024 | 1 | 0.1636 | +0.58% |
| 2023 | 2 | 0.3029 | +1.33% |
| 2022 | 2 | 0.2991 | +1.04% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Listing venues
ESMA register (FIRDS) and official exchange lists
S5SA · Börse Hannover, Tradegate Exchange
+ 3 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE00BHXMHR72
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE00BHXMHR72
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · IE00BHXMHR72 · IE00BHXMHR722